drugset / Trial / NCT00860080
Safety Study Investigating Local Tolerability and Pharmacokinetics of PXL01 in Healthy Volunteers
RandomizedParallel-groupSingle-blind
Summary
The main purpose of this study is to determine whether three different single doses of PXL01 are safe and well tolerated by healthy volunteers. The pharmacokinetic properties of PXL01 (same doses) will also be investigated.
Timeline
- Start
- 2009-03
- Primary completion
- 2009-04
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ENSEREPTIDE | Peptide | 10 mg | Subcutaneous |
| Subject | ENSEREPTIDE | Peptide | 20 mg | Subcutaneous |
| Subject | ENSEREPTIDE | Peptide | 40 mg | Subcutaneous |